Phase 1 multi-center study of safety and feasibility of chemoradiotherapy using oxydol for cervical cancer
Phase 1
- Conditions
- cervical cancer
- Registration Number
- JPRN-UMIN000039045
- Lead Sponsor
- Juntendo University Urayasu Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
less than 20 years old having distant metastasis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1 month after treatment completion, 1 year, 2 years overall survival, disease-free survival and progression-free survival
- Secondary Outcome Measures
Name Time Method Type, severity, and ratio of adverse events that occurred up to the date of follow-up observation